Pharmaceutical firms face many challenges in bringing their products through clinical trials — from enrollment delays to data quality issues — and every advantage can make a difference. In image analysis, sponsors can gain a critical advantage by leveraging artificial intelligence/machine […]
Health Technology Assessment in the U.S. – A Vision for the Future
The USC Schaeffer Center for Health Policy & Economics and the Aspen Institute have together established an advisory panel to consider how the U.S. can better link the price of health technologies to the benefits they provide to patients while ensuring a sustainable healthcare ecosystem that […]
Follow the Dollar Part II
Understanding the Cost of Brand Medicines Administered to Commercially Isured Patients in Hospital Outpatient Departments A new report uncovers the system of incentives that lead hospitals to drive up costs for patients and employers by marking up the price of medicines. While the supply chain for […]
3 Steps for Building your SDOH Business Case
Healthcare organizations recognize the value of SDOH data but simply have no idea where to start. They understand that SDOH factors can improve health outcomes and minimize medical costs, but they often do not fully understand what SDOH data to use to maximize the accuracy of predictive analytics or […]
New Paths in Predictive Payer Coverage: Insights drawing from historical metrics that optimize pre- and post-commercialization marketing efforts for new therapies
Before going to market with a new drug, medical device or test, it’s crucial to know how payers will treat it post-approval. Understanding postlaunch coverage restrictions and knowing which payers are likely to publish policy in the first six months to two years allows organizations to design […]
2021 Medication Access Report
In the 2021 Medication Access Report, hear from patients struggling to afford and access the medications they need, review data on major medication access challenges and discover healthcare solutions that can make a difference. There’s no one way to access medications, but the right way for each […]
Navigating forward: Whole-person care for better health
Reinvent processes, priorities and systems The health care system was designed to treat transactional episodes of care. Now it's under stress from more complex patient needs and the rise of polychronic cases — or people with more than one chronic disease. Polychronic patients are diverse in […]
Navigating forward: A look back and look forward
The rapid response to crisis has altered every aspect of health organizations — including the decision-making considerations of its leadership. This report focuses on highlights from a Becker's advisory call with C-suite health care leaders. This peer-to-peer conversation explored how to adopt […]
Transforming Healthcare with Automated Machine Learning
The future of healthcare is data-driven, and machine learning is key to enabling the artificial intelligence (AI)-driven healthcare organization. Unfortunately, many healthcare providers and payers are struggling to effectively utilize machine learning. Many providers simply don’t have the skills, […]
The Gene Therapy Transformation: A Guide for Managed Care Decision Makers Web Activity
Although gene therapy is a promising treatment option for a number of diseases (including inherited disorders, some types of cancer, and certain viral infections), the technique remains risky and is still under investigation to ensure safety and efficacy. Furthermore, research in this field is […]
How to Mitigate Revenue Cycle Risk During an EHR Implementation
Avoid Common Financial Pitfalls While Seizing RCM Improvement Opportunities. Given the size and scope of an EHR, it’s not surprising that the revenue cycle implications are vast, and an unsuccessful implementation can pose significant financial risks to your organization. To reduce potential […]
Case Study: Bending the Cost Trend for Medicare Advantage Members
When it comes to boosting quality measures, every Member interaction counts. Every aspect of Livongo's digital chronic condition management platform is designed to optimize the Member experience — especially for Medicare populations — to close gaps in care and reduce medical spend. For […]
Responding to COVID-19 with Data: Success Stories
Read COVID-19 success stories from organizations that implemented long-term operational strategies. COVID-19 has laid bare the essential nature of access to comprehensive healthcare analytics. Organizations that have previously relegated advanced analytics as optional or aspirational capabilities […]
How Successful Organizations are Addressing Cost Issues with Data
Read how the most successful hospital organizations are tackling cost-related problems. Labor costs are the single largest expense item for most hospitals, often exceeding 60 percent of net patient revenue. Organizations need to manage their labor spend carefully to curb costs enough to keep pace […]
Addressing Revenue Challenges Using Data: Success Stories
Read how the most successful hospital organizations are tackling revenue-related problems. Healthcare systems routinely confront significant revenue challenges. These financial obstacles include margin compression, increasing costs, the threat of increased debt service, fragmented business […]
Data-informed Care Transformation: Five Success Stories
Read how increased visibility into value-based performance resulted in $2.1M in additional pay for performance in this success story e-book. To provide the highest quality, most appropriate, and most cost-effective care for patients, healthcare organizations must transform around value-based […]
Next-Generation Value-Based Payment Strategies
The U.S. healthcare system is facing a unique and overwhelming set of challenges that are being emphasized by the pandemic. While healthcare stakeholders remain aligned that the value-based care methodology works, scaling and ensuring adoption remain as hurdles. Identifying effective methods to […]
2021 Outlook: Five Themes That Will Define Co-Pay Assistance
As the pharmaceutical industry turns the calendar to 2021, co-pay assistance faces a handful of significant considerations that will define how successful manufacturer programs are in the year ahead. From legislative and regulatory issues to the shift toward integrated offerings and interoperable […]
Take your market access to the next level: your free digital transformation eBook
This free eBook gives you a collection of our best digital transformation articles, case studies, and on-demand webinars. The recommendations for kick-starting digital transformation within your organization will also help you decide which of our digital applications will support your unique market […]
How Healthy Are Your Market Access Programs? A guide to performing check-ups on pharmaceutical distribution and patient access programs
Pharmaceutical manufacturers invest countless resources to develop product distribution and patient access programs to maximize product success. But eventually most programs will experience service disruptions, face unforeseen challenges, and receive negative feedback from stakeholders. Why does […]
Data removes the barriers to understanding rare disease
7,000. That’s the estimated number of distinct types of rare and genetic diseases affecting more than 400 million people around the world. Yet 95% of rare diseases lack an FDA-approved product for treatment. Even with the Orphan Drug Act, there are many daunting barriers that stand between […]
The Future Was Today
On October 6, PulsePoint held its second annual Digital Health Forum, “The Future Was Today,” focused on finding the upside of change in an ever-fluid marketplace, and taking a closer look at how an acceleration in companies’ adoption of data and technology is helping to drive better health […]
How Can a Supply Chain Dashboard Yield Greater Clinical Trial Insights, Cost Control, and Efficiency?
With 1 in 10 Sponsors identifying a lack of technology integration as their biggest pain point, Deighton Liverpool, Ancillare’s Chief Information Officer addresses the critical need. And dives into what Ancillare is doing to bring sophisticated Clinical Trial Ancillary Supply Chain (CTASC) […]
Strategies for Engaging Vulnerable Populations in Healthcare
Connecting and communicating with members is an important part of effective healthcare. When providers and members work as a team, health outcomes improve. Members who have access to factual and high-quality health information, guidance from a qualified healthcare provider, and who can connect and […]
Tracing the health care experience informs decision-making
Mapping the patient journey is a worthwhile exercise to undertake because it answers critical questions of interest to all health care stakeholders. The richness of patient journey mapping can help develop patient cohorts and assess effectiveness of therapeutics. Total health care utilization and […]
Driving More Value and Cost Savings With SDOH Data
Getting a Social Determinant of Health (SDOH) initiative off the ground requires thoughtful coordination and analysis between analytics teams, clinicians, social workers and others, and buy-in from leadership. SDOH data includes details about income, education, race, gender and other social […]
Advancing Early Stage Oncology Research with Adaptive Designs and Master Protocols
Oncology trials make up over a third of today’s pharmaceutical research pipeline, but conventional oncology drug development programs are often inefficient, expensive, and suffer from high failure rates. Of the oncology agents that enter Phase I trials, only about 3% eventually receive approval from […]
Transformation of Clinical Trial Design and Operations
Recently, Brittany Erana, MPM, Vice President of PPD® Digital; and Niklas Morton, MSc, Senior Vice President of PPD® Digital, spoke with leaders of Science 37, Medable, and Takeda in an online forum about how the industry is shifting to focus on decentralized trials. They then took questions from […]
Using real-world data to close the rare disease data gap
Research and drug development for rare and genetic diseases is challenging without insight into history and clinical manifestations. Missing efficacy endpoints and underrepresentation in medical coding systems further hinder our understanding of rare disease. Real-world data (RWD) closes this […]
Analysis and Insights from Real-World Clinical Registries: RA, GCA, JIA, & SLE
This report pulls together key findings from the OM1™ Real-World Data Cloud and some of OM1's clinical registries. The report covers examples of applications for real-world data and machine learning in evaluating real-world outcomes and is broken into four chapters: Rheumatoid Arthritis […]
